Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Gastric Retentive Carbidopa/ Levodopa in Parkinson's Patients; a One Year, Open Label, Safety Extension Study

This study has been withdrawn prior to enrollment.
(The sponsor decided to postpone the performance of this study to after phase 3)
Sponsor:
Information provided by (Responsible Party):
Intec Pharma Ltd.
ClinicalTrials.gov Identifier:
NCT00947037
First received: July 24, 2009
Last updated: November 23, 2015
Last verified: September 2012
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: No date given
  Primary Completion Date: August 2012 (Final data collection date for primary outcome measure)